No profile data available.
Revium Rx (RVRC) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Herzliya, Israel, with about 3 full-time employees.
Its market capitalization was $86.84 million as of October 8, 2026.
Figures from company filings and market data; market data as of October 8, 2026.
Revium Rx. operates as a pre-clinical stage biopharmaceutical company focused on the development of nanoparticle-based therapies in the United States.
$86.84 million as of October 8, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Avidity Biosciences, Inc. (RNA), vTv Therapeutics Inc. (VTVT), Vivani Medical, Inc. (VANI), Telomir Pharmaceuticals, Inc. (TELO).